Buy Aurobindo Pharma, target price Rs 485: ICICI Securities

Taking Sandoz out of estimates, the brokerage now expects consolidated revenue growth in mid-single digit for Aurobindo over the next two years.

from Markets-Economic Times https://ift.tt/2Rheltr